Provided by Tiger Trade Technology Pte. Ltd.

Enveric Biosciences

1.43
+0.04002.88%
Volume:89.15K
Turnover:124.77K
Market Cap:6.40M
PE:-0.19
High:1.44
Open:1.40
Low:1.38
Close:1.39
52wk High:17.64
52wk Low:1.25
Shares:4.48M
Float Shares:4.34M
Volume Ratio:0.40
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4858
EPS(LYR):-36.2437
ROE:-170.04%
ROA:-87.34%
PB:0.79
PE(LYR):-0.04

Loading ...

Cancer Immunotherapy Developer CEL-SCI's Q3 Net Loss Unchanged

Reuters
·
Aug 17

Enveric Biosciences Q2 EPS $(0.76) Up From $(11.64) YoY

Benzinga Earnings
·
Aug 15

Enveric Net Loss Narrows to $3 Million in Q2 FY26; Loss Per Share Improves to $0.76

Reuters
·
Aug 15

Enveric Biosciences Q2 Net Income USD -3 Million

THOMSON REUTERS
·
Aug 15

Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Second Quarter 2026

Dow Jones
·
Aug 15

Enveric Biosciences Says Preclinical GloSensor Assay Supports Non-Hallucinogenic Profile for EB-003

Reuters
·
Aug 05

Enveric Welcomes Final FDA Guidance on Psychedelic Drug Trials

Reuters
·
Jul 28

Enveric Biosciences to Feature at B. Riley Securities Summit, Highlighting Neuroplastogen Development

Deep News
·
Jun 30

Enveric Biosciences CEO Joins B. Riley Securities Neuropsychiatry Fireside Chat at Mind, Muscle & Vision Summit

Reuters
·
Jun 29

Enveric Biosciences to attend BIO International Convention

Reuters
·
Jun 16

Enveric Biosciences Expands At-The-Market Equity Offering

TIPRANKS
·
Jun 10

Enveric Biosciences files prospectus supplement to offer additional $2.43 million in shares via ATM agreement

Reuters
·
Jun 10

Enveric Biosciences to attend UBS Virtual CNS Day

Reuters
·
Jun 09

Enveric Biosciences Begins Genotoxicity Testing for EB-003

MT Newswires Live
·
Jun 02

Enveric Biosciences starts IND-enabling genotoxicity studies for lead neuroplastogen EB-003

Reuters
·
Jun 02

Enveric Biosciences Initiates Investigational New Drug (Ind)-Enabling Genotoxicity Studies of Lead Neuroplastogen Candidate Eb-003

THOMSON REUTERS
·
Jun 02

Enveric Biosciences - Initiates Ind-Enabling Genotoxicity Studies for Eb-3

THOMSON REUTERS
·
Jun 02

Enveric Biosciences Shareholders Approve Directors and Reverse Split

TIPRANKS
·
May 30

Enveric says EB-003 shows no phototoxicity risk in preclinical analysis

Reuters
·
May 19

Enveric Biosciences Inc - Eb-003 First Known Compound to Selectively Engage 5-Ht2a and 5-Ht1b Receptors

THOMSON REUTERS
·
May 19